185 related articles for article (PubMed ID: 29940232)
1. Cognitive Versus Software Fusion for MRI-targeted Biopsy: Experience Before and After Implementation of Fusion.
Monda SM; Vetter JM; Andriole GL; Fowler KJ; Shetty AS; Weese JR; Kim EH
Urology; 2018 Sep; 119():115-120. PubMed ID: 29940232
[TBL] [Abstract][Full Text] [Related]
2. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM
Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655
[TBL] [Abstract][Full Text] [Related]
3. The FUTURE Trial: A Multicenter Randomised Controlled Trial on Target Biopsy Techniques Based on Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer in Patients with Prior Negative Biopsies.
Wegelin O; Exterkate L; van der Leest M; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE
Eur Urol; 2019 Apr; 75(4):582-590. PubMed ID: 30522912
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study.
Puech P; Rouvière O; Renard-Penna R; Villers A; Devos P; Colombel M; Bitker MO; Leroy X; Mège-Lechevallier F; Comperat E; Ouzzane A; Lemaitre L
Radiology; 2013 Aug; 268(2):461-9. PubMed ID: 23579051
[TBL] [Abstract][Full Text] [Related]
5. Is There Still a Need for Repeated Systematic Biopsies in Patients with Previous Negative Biopsies in the Era of Magnetic Resonance Imaging-targeted Biopsies of the Prostate?
Exterkate L; Wegelin O; Barentsz JO; van der Leest MG; Kummer JA; Vreuls W; de Bruin PC; Bosch JLHR; van Melick HHE; Somford DM
Eur Urol Oncol; 2020 Apr; 3(2):216-223. PubMed ID: 31239236
[TBL] [Abstract][Full Text] [Related]
6. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
[TBL] [Abstract][Full Text] [Related]
7. A Comparative Study of Prostate Cancer Detection Rate Between Transperineal COG-TB and Transperineal FUS-TB in Patients with PSA ≤20 ng/mL.
Liang L; Cheng Y; Qi F; Zhang L; Cao D; Cheng G; Hua L
J Endourol; 2020 Oct; 34(10):1008-1014. PubMed ID: 32600058
[No Abstract] [Full Text] [Related]
8. Complications and Adverse Events of Three Magnetic Resonance Imaging-based Target Biopsy Techniques in the Diagnosis of Prostate Cancer Among Men with Prior Negative Biopsies: Results from the FUTURE Trial, a Multicentre Randomised Controlled Trial.
Wegelin O; Exterkate L; van der Leest M; Kelder JC; Bosch JLHR; Barentsz JO; Somford DM; van Melick HHE
Eur Urol Oncol; 2019 Nov; 2(6):617-624. PubMed ID: 31519516
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic yield of fusion magnetic resonance-guided prostate biopsy versus cognitive-guided biopsy in biopsy-naive patients: a head-to-head randomized controlled trial.
Izadpanahi MH; Elahian A; Gholipour F; Khorrami MH; Zargham M; Mohammadi Sichani M; Alizadeh F; Khorrami F
Prostate Cancer Prostatic Dis; 2021 Dec; 24(4):1103-1109. PubMed ID: 33907293
[TBL] [Abstract][Full Text] [Related]
10. Cognitive versus Software-Assisted Registration: Development of a New Nomogram Predicting Prostate Cancer at MRI-Targeted Biopsies.
Kaufmann S; Russo GI; Thaiss W; Notohamiprodjo M; Bamberg F; Bedke J; Morgia G; Nikolaou K; Stenzl A; Kruck S
Clin Genitourin Cancer; 2018 Aug; 16(4):e953-e960. PubMed ID: 29685613
[TBL] [Abstract][Full Text] [Related]
11. The Role of Ipsilateral and Contralateral Transrectal Ultrasound-guided Systematic Prostate Biopsy in Men With Unilateral Magnetic Resonance Imaging Lesion Undergoing Magnetic Resonance Imaging-ultrasound Fusion-targeted Prostate Biopsy.
Bryk DJ; Llukani E; Taneja SS; Rosenkrantz AB; Huang WC; Lepor H
Urology; 2017 Apr; 102():178-182. PubMed ID: 27871829
[TBL] [Abstract][Full Text] [Related]
12. Additional value of magnetic resonance-targeted biopsies to standard transrectal ultrasound-guided biopsies for detection of clinically significant prostate cancer.
von Below C; Wassberg C; Norberg M; Tolf A; Kullberg J; Ladjevardi S; Häggman M; Bill Axelson A; Ahlström H
Scand J Urol; 2017 Apr; 51(2):107-113. PubMed ID: 28635568
[TBL] [Abstract][Full Text] [Related]
13. Predictive Parameters Identifying Men Eligible for a Sole MRI/Ultrasound Fusion-Guided Targeted Biopsy without an Additional Systematic Biopsy.
Günzel K; Haas M; Maxeiner A; Stephan C; Buckendahl J; Asbach P; Miller K; Kempkensteffen C; Cash H
Urol Int; 2017; 98(1):15-21. PubMed ID: 27618633
[TBL] [Abstract][Full Text] [Related]
14. Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen.
Lian H; Zhuang J; Wang W; Zhang B; Shi J; Li D; Fu Y; Jiang X; Zhou W; Guo H
BMC Urol; 2017 Jul; 17(1):52. PubMed ID: 28679370
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of magnetic resonance imaging targeted biopsy techniques compared to transrectal ultrasound guided biopsy of the prostate: a systematic review and meta-analysis.
Bass EJ; Pantovic A; Connor MJ; Loeb S; Rastinehad AR; Winkler M; Gabe R; Ahmed HU
Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):174-179. PubMed ID: 34548624
[TBL] [Abstract][Full Text] [Related]
16. Comparison of free-hand transperineal mpMRI/TRUS fusion-guided biopsy with transperineal 12-core systematic biopsy for the diagnosis of prostate cancer: a single-center prospective study in China.
Zhang Q; Wang W; Zhang B; Shi J; Fu Y; Li D; Guo S; Zhang S; Huang H; Jiang X; Zhou W; Guo H
Int Urol Nephrol; 2017 Mar; 49(3):439-448. PubMed ID: 28005230
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of MRI/TRUS fusion-guided biopsies vs. systematic prostate biopsies in biopsy-naïve, previous negative biopsy patients and men undergoing active surveillance.
Borghesi M; Bianchi L; Barbaresi U; Vagnoni V; Corcioni B; Gaudiano C; Fiorentino M; Giunchi F; Chessa F; Garofalo M; Bertaccini A; Angelini S; Ercolino A; Casablanca C; Droghetti M; Golfieri R; Schiavina R
Minerva Urol Nephrol; 2021 Jun; 73(3):357-366. PubMed ID: 33769008
[TBL] [Abstract][Full Text] [Related]
18. Surface-projection-based transperineal cognitive fusion targeted biopsy of the prostate: an original technique with a good cancer detection rate.
Wang L; Wang X; Zhao W; Zhao Z; Li Z; Fei S; Zhu H; Ji X; Yang B; Li N; Na Y
BMC Urol; 2019 Nov; 19(1):107. PubMed ID: 31684917
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric magnetic resonance imaging/transrectal ultrasound fusion targeted biopsy of the prostate: preliminary results of a prospective single-centre study.
Junker D; Schäfer G; Heidegger I; Bektic J; Ladurner M; Jaschke W; Aigner F
Urol Int; 2015; 94(3):313-8. PubMed ID: 25591786
[TBL] [Abstract][Full Text] [Related]
20. Targeted vs systematic robot-assisted transperineal magnetic resonance imaging-transrectal ultrasonography fusion prostate biopsy.
Mischinger J; Kaufmann S; Russo GI; Harland N; Rausch S; Amend B; Scharpf M; Loewe L; Todenhoefer T; Notohamiprodjo M; Nikolaou K; Stenzl A; Bedke J; Kruck S
BJU Int; 2018 May; 121(5):791-798. PubMed ID: 29211932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
